Goodman Financial Corp purchased a new stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 75,165 shares of the medical technology company's stock, valued at approximately $13,378,000. Teleflex comprises approximately 2.9% of Goodman Financial Corp's holdings, making the stock its 19th biggest position. Goodman Financial Corp owned approximately 0.16% of Teleflex as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also made changes to their positions in the company. Vontobel Holding Ltd. raised its stake in shares of Teleflex by 21.9% in the 4th quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company's stock valued at $248,000 after acquiring an additional 250 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Teleflex by 14.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company's stock valued at $38,374,000 after buying an additional 19,466 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its holdings in Teleflex by 5.2% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company's stock worth $19,263,000 after acquiring an additional 5,322 shares during the period. Lecap Asset Management Ltd. acquired a new position in Teleflex during the 4th quarter worth $729,000. Finally, Mirae Asset Global Investments Co. Ltd. boosted its holdings in Teleflex by 35.1% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company's stock valued at $1,053,000 after acquiring an additional 1,527 shares during the period. Institutional investors own 95.62% of the company's stock.
Teleflex Price Performance
Shares of NYSE TFX traded down $2.18 during trading on Tuesday, reaching $139.35. The company had a trading volume of 1,145,054 shares, compared to its average volume of 548,453. Teleflex Incorporated has a 52 week low of $128.55 and a 52 week high of $249.91. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The business's 50 day moving average price is $162.43 and its 200-day moving average price is $192.97. The stock has a market cap of $6.46 billion, a PE ratio of 27.70, a PEG ratio of 1.73 and a beta of 1.21.
Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.86 by $0.03. The firm had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.
Teleflex Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were given a $0.34 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 0.98%. Teleflex's payout ratio is 95.77%.
Analyst Ratings Changes
A number of research analysts have recently commented on the company. Citizens Jmp lowered Teleflex from an "outperform" rating to a "market perform" rating in a report on Thursday, February 27th. Royal Bank of Canada downgraded shares of Teleflex from an "outperform" rating to a "sector perform" rating and reduced their price target for the company from $220.00 to $155.00 in a report on Friday, February 28th. Bank of America downgraded shares of Teleflex from a "neutral" rating to an "underperform" rating and dropped their price objective for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Piper Sandler reiterated a "neutral" rating and issued a $140.00 target price (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Teleflex has an average rating of "Hold" and a consensus target price of $182.63.
Check Out Our Latest Stock Report on TFX
Teleflex Profile
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Further Reading
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
